The landscape of dementia diagnosis has evolved drastically with the advent of complex biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based assessments that can detect Alzheimer's pathology a long time before indicators arise. Whilst these technological advancements represent exceptional progress in knowledge neurode